PETALING JAYA: Merger and acquisition (M&A) activity in Malaysia should remain healthy in the second half of the year (2H22) as deals in gestation are on track to be completed but rising finance costs and cautiousness could slow new deal numbers.
Deloitte Malaysia M&A leader Yap Kong Meng told StarBiz there would be a contrast in new M&As in 2H22 as macro headwinds such as rising interest rates and rising raw material prices continue or worsen and impact valuations.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
